2020-12-31-accounts - The British Gynaecological Cancer Society

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

					31.12.20	31.12.19
			Unrestricted	Restricted	Total	Total
			fund	fund	funds	funds
		Notes
INCOME AND ENDOWMENTS FROM
Donations and legacies		2				4,550
Charitable activities		4
To advance the science	and ait ofgynaecological
oncology for the benefit ofthe public			51,532		51,532	329,607
Investment income			144		144	202
Total			51,676		51,676	334,439
EXPENDITURE ON
Charitable activities		5
To advance the science	and art ofgynaecological
oncology for the benefit ofthe public			77,229		77,229	209,340
NET INCOME/(EXPENDITURE)			(25,553)		(25,553)	125,099
RECONCILIATION	OF FUNDS
Total funds brought forward			467,019		467,019	341,920
TOTAL FUNDS CARRIED FORWARD			441,466		441,466	467,019

				31.12.20	31.12.19
		Unrestricted	Restricted	Total	Total
		fund	fund	funds	funds
	Notes
CURRENT ASSETS
Debtors	10	2,040		2,040	151,226
Cash at bank		453,469		453,469	340,409
		455,509		455,509	491,635
CREDITORS
Amounts falling due within one year	11	(14,043)		(14,043)	(24,616)
NET CURRENT ASSETS		441,466		441,466	467,019
TOTAL ASSETSLESSCURRENT
LIABILITIES		441,466		441,466	467,019
NET ASSETS		441,466		441,466	467,019
FUNDS	12
Unrestricted funds				441,466	467,019
TOTAL FUNDS				441,466	467,019

			2019
Mason	Relief Scheme		250
National	Federation ofGynaeoncology	Nurses	4300
Total			4,550

3.	INVESTMENT INCOME	INVESTMENT INCOME
				31.12.20	31.12.19
	Deposit account	interest		144	282
	INCOME FROM CHARITABLE ACTIVITIES
				31.12.20	31.12.19
		Activity
		To advance the	science and art of
		gynaecological	oncology for the benefit of
	Sponsorships	the public		6,883	176,753
		To advance the	science and art of
		gynaecological	oncology for the benefit of
	Delegate fees	the public		785	114,490
		To advance the	science and artof
		gynaecological	oncology for the benefit of
	Subscriptions	the public		43,864	38,364
				51,532	329,607
5.	CHARITABLE ACTIVITIES COSTS
				Support
			Direct	costs (see
			Costs	note 6)	Totals
	To advance the	science and art of
	gynaecological	oncology for the benefit
	ofthe public		59,107	18,122	77&229
6.	SUPPORT COSTS
				Governance
			Management	costs	Totals
					f.
	To advance the	science and art of
	gynaecological	oncology for the benefit of
	the public		15,606	2,516	18,122

Independent examiner's	fees
Other assurance services

Trustees' expenses
			31.12.20	31.12.19
			8
Trustees' expenses			516	3,304
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
		Unrestricted	Restricted	Total
		fund	fund	funds
INCOME AND ENDOWMENTS FROM
Donations and legacies		4,550		4,550
Charitable activities
To advance the science and art of
gynaecological oncology for the benefit ofthe
public		329,607		329,607
Investment income		282		282
Total		334,439		334,439
EXPENDITURE ON
Charitable activities
To advance the science and art of
gynaecological oncology for the benefit ofthe
public		209,340		209,340
NET INCOME		125,099		125,099
RECONCILIATION	OF FUNDS
Total funds brought	forward
As previously reported		347,854		347,854
Prior year adjustment		(5,934)		(5,934)
As restated		341,920		341,920

9.	COMPARATIVES FORTHE	COMPARATIVES FORTHE	COMPARATIVES FORTHE	COMPARATIVES FORTHE	STATEMENT OF FINANCIAL	ACTIVITIES	ACTIVITIES	-continued
						Unrestricted		Restricted	Total
							fund	fund	funds
								f
	TOTAL	FUNDS CARRIED FORWARD				467,019			467,019
10.	DEBTORS:		AMOUNTS FALLING DUE WITHIN ONE YEAR
								31,12.20	31.12.19
	Other debtors								150,034
	Prepayrnents							2,040	1,192
								2,040	151,226
11.	CREDITORS:			AMOUNTS FALLING DUE WITHIN ONE YEAR
								31.12.20	31.12.19
	Trade creditors							11,254	2,081
	VAT							1,289	20,935
	Accrued	expenses						1,500	1,600
								14,043	24,616
12.	MOVEMENT			IN FUNDS
								Net
								movement	At
						At	1.1.20	in funds	31.12.20
	Unrestricted		funds
	General	fund				467,019		(25,553)	441,466
	TOTAL	FUNDS				467,019		(25,553)	441,466
	Net movement			in funds, included	in the above are as follows:
						Incoming		Resources	Movement
						resources		expended	in funds
	Unrestricted		funds
	General	fund				51,676		(77,229)	(25,553)
	TOTAL	FUNDS				51,676		(77,229)	(25,553)

			Incoming	Resources	Movement
			resources	expended	in funds
Unrestricted	funds
General fund			334,439	(209,340)	125,099
TOTAL FUNDS			334,439	(209,340)	125,099
A current year	12months	and prior year 12months combined	position is as follows:
			Prior	Net
			year	movement	At
		At 1.1.19	adjustment	in funds	31.12.20
Unrestricted	funds
General fund		347,854	(5,934)	99,546	441,466
TOTAL FUNDS		347,854	(5,934)	99,546	441,466